These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36906250)

  • 1. A comprehensive perspective of Huntington's disease and mitochondrial dysfunction.
    Dai Y; Wang H; Lian A; Li J; Zhao G; Hu S; Li B
    Mitochondrion; 2023 May; 70():8-19. PubMed ID: 36906250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease.
    Wang Y; Guo X; Ye K; Orth M; Gu Z
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington's disease.
    Vanisova M; Stufkova H; Kohoutova M; Rakosnikova T; Krizova J; Klempir J; Rysankova I; Roth J; Zeman J; Hansikova H
    Ultrastruct Pathol; 2022 Sep; 46(5):462-475. PubMed ID: 35946926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.
    Cherubini M; Ginés S
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1063-1068. PubMed ID: 27514446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shaping the role of mitochondria in the pathogenesis of Huntington's disease.
    Costa V; Scorrano L
    EMBO J; 2012 Apr; 31(8):1853-64. PubMed ID: 22446390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease.
    Guo X; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):552-559. PubMed ID: 27913212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitophagy in Huntington's disease.
    Šonský I; Vodička P; Vodičková Kepková K; Hansíková H
    Neurochem Int; 2021 Oct; 149():105147. PubMed ID: 34329735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Dysfunction in Huntington's Disease: Pathogenesis and Therapeutic Opportunities.
    Sharma A; Behl T; Sharma L; Aelya L; Bungau S
    Curr Drug Targets; 2021; 22(14):1637-1667. PubMed ID: 33655829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease: a clinical review.
    McColgan P; Tabrizi SJ
    Eur J Neurol; 2018 Jan; 25(1):24-34. PubMed ID: 28817209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.
    Fu Z; Liu F; Liu C; Jin B; Jiang Y; Tang M; Qi X; Guo X
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1428-1435. PubMed ID: 30802639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial matters of the brain: the role in Huntington's disease.
    Turner C; Schapira AH
    J Bioenerg Biomembr; 2010 Jun; 42(3):193-8. PubMed ID: 20480217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial structural and functional dynamics in Huntington's disease.
    Reddy PH; Mao P; Manczak M
    Brain Res Rev; 2009 Jun; 61(1):33-48. PubMed ID: 19394359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of the Bcl-2 family proteins in Huntington's disease.
    Sassone J; Maraschi A; Sassone F; Silani V; Ciammola A
    Cell Death Dis; 2013 Aug; 4(8):e772. PubMed ID: 23949221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Huntington's Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies.
    Irfan Z; Khanam S; Karmakar V; Firdous SM; El Khier BSIA; Khan I; Rehman MU; Khan A
    Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly.
    Mejia EM; Chau S; Sparagna GC; Sipione S; Hatch GM
    Lipids; 2016 May; 51(5):561-9. PubMed ID: 26846325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial protein import by mutant huntingtin.
    Yano H; Baranov SV; Baranova OV; Kim J; Pan Y; Yablonska S; Carlisle DL; Ferrante RJ; Kim AH; Friedlander RM
    Nat Neurosci; 2014 Jun; 17(6):822-31. PubMed ID: 24836077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.
    Quintanilla RA; Johnson GV
    Brain Res Bull; 2009 Oct; 80(4-5):242-7. PubMed ID: 19622387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients.
    Jędrak P; Mozolewski P; Węgrzyn G; Więckowski MR
    Metab Brain Dis; 2018 Dec; 33(6):2005-2017. PubMed ID: 30120672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
    Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
    Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.